NIH-funded research R01 grant

Quick testing for antibiotic resistance in bacteria from blood samples

Official title: Rapid Antibiotic Susceptibility Testing via Selective Lysis and Nanogap Trapping

Funded at Univ of Maryland, College Park · NIH-11110065 · Data updated 2026-11-12

This study is working on a quick way to test how bacteria in your blood react to antibiotics, so doctors can make faster and better treatment decisions when you're sick.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Maryland, College Park
NIH-funded
Lab location1 site (College Park, United States)
Project startApril 10, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$490,093
NIH project number1R01AI190349-01
Project IDNIH-11110065 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients presenting with acute bacterial infections who require timely antibiotic treatment.

Less likely to help

Patients with viral infections or those who do not require antibiotic therapy may not benefit from this research.

What this research studies

This research aims to develop a rapid method for testing how bacteria respond to antibiotics directly from blood samples. By using a microfluidic technology, the project will isolate bacteria from blood, identify the pathogens, and assess their susceptibility to antibiotics within 75 minutes. This approach seeks to overcome the limitations of current testing methods that are often too slow for timely treatment decisions, especially during critical early stages of infection. The goal is to provide clinicians with faster and more accurate information to guide antibiotic therapy, ultimately improving patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to faster and more effective treatment of bacterial infections, reducing complications and healthcare costs associated with antibiotic resistance.

How similar studies have gone: Other research has shown promise in rapid antibiotic susceptibility testing, but this specific approach using microfluidic technology is relatively novel.

Where this research is happening

  • Univ of Maryland, College Park
    College Park, United States
    Active

Researchers

  • Principal investigator: Devoe, Don L — Univ of Maryland, College Park
  • Study coordinator: Devoe, Don L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.